SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.335-2.6%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: BulbaMan who wrote ()11/19/1996 5:23:00 PM
From: louis mason   of 3578
 
Dear Marty,

The info. about the time article is interesting- especially from a public relations standpoint. What about the science! The telomerase/telomere model has some interesting implications for a biological "clock," but is it currently applicable?

Is Geron going to be able to develop any anti-aging or anti-cancer drugs in the near term? Do you see anti-telomerase agents as being effective against carcinomas?

I noticed Gerons release of the TRAP-EZE kit product through Oncor. Is this selling well? How many units have they sold so far, and was there selling target reached?

Are any large pharmaceuticals who are in talks with Geron? What about contracts for screening non-nucleoside reverse transcriptase inhibitors?

Are we going to make some money here or not, Marty?

Looking forward to if we can get a thread going, louis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext